<DOC>
	<DOCNO>NCT00356148</DOCNO>
	<brief_summary>This single center trial compare rate surgical site infection ( SSI ) normal ( BMI equal less 25 ; Control Group ) ) overweight ( BMI 25 ) woman undergo breast cancer surgery . The overweight patient randomize two group ; one group patient receive prophylactic antibiotic ( ampicillin/sulbactam ; Prophylaxis Group ) , ( No Prophylaxis Group ) .</brief_summary>
	<brief_title>The Efficacy Prophylactic Antibiotic Administration During Breast Cancer Surgery Overweight Patients .</brief_title>
	<detailed_description>CONTEXT Although breast surgery regard clean surgery , actual SSI rate well accept range various series . Retrospective study show BMI one factor may cause increased SSI rate breast cancer surgery . Yet , prospective randomize study assess efficacy chemoprophylaxis breast surgery overweight patient . OBJECTIVE To compare SSI rate three group early stage breast cancer patient two assign accord randomization . First , patient group two accord BMI . All patient ( Control Group ) BMI equal 25 receive antibiotic prophylaxis . Patients BMI 25 randomly assign receive single dose prophylactic ampicillin /sulbactam combination surgery ( Prophylaxis Group ) receive chemoprophylaxis ( No Prophylaxis Group ) . DESIGN , SETTING AND PATIENTS Patient recruitment still continue study start October 2003 order reach sample size 360 patient BMI 25 . Advanced distant metastatic stage , receive neoadjuvant therapy , history receive antibiotic within prior 3 month , history immunodeficiency , remote infection history reaction treatment antibiotic within exclusion criterion . INTERVENTIONS All patient follow 30 day postoperatively ( week original surgical unit ) . Patients investigator inspects wound blind . Cost SSI-related prophylaxis treatment ( include additional hospital visit discharge , physician charge , additional antibiotic , wound management , drug intervention etc ) calculate study group compare .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Sulbactam</mesh_term>
	<mesh_term>Sultamicillin</mesh_term>
	<mesh_term>Ampicillin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Women age early stage breast cancer ( stage III ) American Society Anesthesiologists ( ASA ) score III . Ductal carcinoma situ ( DCIS ; stage 0 cancer ) , Advanced distant metastatic stage , Receiving neoadjuvant therapy , History receive antibiotic within prior 3 month , History immunodeficiency , Having remote infection , History reaction study antibiotic , Denial sign consent form .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>breast surgery</keyword>
	<keyword>clean wound</keyword>
	<keyword>overweight</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>antibiotic</keyword>
</DOC>